Wolverine Trading’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Wolverine Trading’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$297K	Buy	+4,200	New	+$290K	﹤0.01%	4395
2020 Q1	–	Sell	-6,000	Closed	-$319K	–	4913
2019 Q4	$319K	Sell	6,000 -1,500	-20%	-$73.9K	﹤0.01%	3513
2019 Q3	$348K	Buy	+7,500	New	+$359K	﹤0.01%	3006
2019 Q2	–	Sell	-4,500	Closed	-$231K	–	4767
2019 Q1	$231K	Buy	+4,500	New	+$224K	﹤0.01%	3656
2018 Q4	–	Sell	-14,400	Closed	-$806K	–	4847
2018 Q3	$806K	Buy	+14,400	New	+$787K	﹤0.01%	2578
2017 Q4	–	Sell	-7,500	Closed	-$391K	–	5152
2017 Q3	$391K	Buy	+7,500	New	+$385K	﹤0.01%	2909
2017 Q1	–	Sell	-31,200	Closed	-$1.47M	–	4610
2016 Q4	$1.47M	Buy	+31,200	New	+$1.48M	0.01%	1586

Other funds holding IHE

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Wolverine Trading's IHE Position: Q4 2019 in Review

Wolverine Trading sold out of iShares US Pharmaceuticals ETF (IHE) in Q4 2019, closing a stake of 4,614 shares — an estimated $227K sold.

Wolverine Trading first reported a position in IHE in Q4 2016 and held it in 2 quarters. The position peaked at $436K in Q4 2016. 95 funds tracked by Wall St. Rank hold IHE as of Q4 2019.

Wolverine Trading reported no remaining iShares US Pharmaceuticals ETF position as of Q4 2019 after selling out during the quarter.
Wolverine Trading sold 4,614 iShares US Pharmaceuticals ETF shares in Q4 2019, an estimated $227K.
Wolverine Trading first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 2 quarters.
Wolverine Trading's iShares US Pharmaceuticals ETF position peaked at $436K in Q4 2016.
95 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.